Ildefonso Rodriguez-Rivera

Phase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma

Alison J. Moskowitz, Gunjan L. Shah, Heiko Schöder et al. · Journal of Clinical Oncology · 2021 · 199 citations · Full text

Medicine, Oncology, Pharmacology +13

Outcomes in patients with DLBCL treated with commercial CAR T cells compared with alternate therapies

David Sermer, Connie Lee Batlevi, M. Lia Palomba et al. · Blood Advances · 2020 · 117 citations · Full text

Medicine, Hematology, Oncology +17

Extra copies of MYC, BCL2, and BCL6 and outcome in patients with diffuse large B-cell lymphoma

David Sermer, Sabela Bobillo, Ahmet Doǧan et al. · Blood Advances · 2020 · 14 citations · Full text

Medicine, Hematology, Oncology +16

Precemtabart tocentecan, an anti-CEACAM5 antibody–drug conjugate, in metastatic colorectal cancer: a phase 1 trial

Scott Kopetz, Valentina Boni, Ken Kato et al. · Nature Medicine · 2025 · 14 citations · Full text

Medicine, Oncology, Pharmacology +17

Interim Analysis from a Prospective Multicenter Study of Next-Generation Sequencing Minimal Residual Disease Assessment and CT Monitoring for Surveillance after Frontline Treatment in Diffuse Large B-Cell Lymphoma

Anita Kumar, Jason R. Westin, Stephen J. Schuster et al. · Blood · 2020 · 10 citations

Medicine, Oncology, Radiology +17